tetano
Editor, Senior Moderator
Cureus
. 2022 Feb 22;14(2):e22486.
doi: 10.7759/cureus.22486. eCollection 2022 Feb.
Threat of Staphylococcus aureus Pneumonia in Severe COVID-19 Patients
Shuichi Tanaka[SUP] 1 [/SUP], Koichiro Yamamoto[SUP] 1 [/SUP], Hideharu Hagiya[SUP] 1 [/SUP], Kou Hasegawa[SUP] 1 [/SUP], Fumio Otsuka[SUP] 1 [/SUP]
Affiliations
Abstract
Coronavirus disease 2019 (COVID-19) has been spreading worldwide with unprecedented rapidity. Staphylococcus aureus is reported to frequently cause bacterial complications in patients with COVID-19. We herein present two additional cases of S. aureus pneumonia involving such patients. The first case was an obese 48-year-old man without any particular underlying diseases. The second case was another patient, a 72-year-old man, with hypertension, dyslipidemia, and steatohepatitis. Both patients developed methicillin-susceptible S. aureus pneumonia in the clinical course of COVID-19, to which antibiotic therapy with cefazolin was effectively administered. Through these cases, we emphasize that S. aureus secondary infections should be well cared with a high degree of caution in a case of critically ill COVID-19 patients.
Keywords: coronavirus disease 2019; pneumonia; staphylococcus aureus; superinfection; ventilation.
. 2022 Feb 22;14(2):e22486.
doi: 10.7759/cureus.22486. eCollection 2022 Feb.
Threat of Staphylococcus aureus Pneumonia in Severe COVID-19 Patients
Shuichi Tanaka[SUP] 1 [/SUP], Koichiro Yamamoto[SUP] 1 [/SUP], Hideharu Hagiya[SUP] 1 [/SUP], Kou Hasegawa[SUP] 1 [/SUP], Fumio Otsuka[SUP] 1 [/SUP]
Affiliations
- PMID: 35345748
- PMCID: PMC8942142
- DOI: 10.7759/cureus.22486
Abstract
Coronavirus disease 2019 (COVID-19) has been spreading worldwide with unprecedented rapidity. Staphylococcus aureus is reported to frequently cause bacterial complications in patients with COVID-19. We herein present two additional cases of S. aureus pneumonia involving such patients. The first case was an obese 48-year-old man without any particular underlying diseases. The second case was another patient, a 72-year-old man, with hypertension, dyslipidemia, and steatohepatitis. Both patients developed methicillin-susceptible S. aureus pneumonia in the clinical course of COVID-19, to which antibiotic therapy with cefazolin was effectively administered. Through these cases, we emphasize that S. aureus secondary infections should be well cared with a high degree of caution in a case of critically ill COVID-19 patients.
Keywords: coronavirus disease 2019; pneumonia; staphylococcus aureus; superinfection; ventilation.